Investors & Media


Altamira Therapeutics is dedicated to developing therapeutics that address important unmet medical needs. The Company is currently active in RNA therapeutics, allergy and viral infections, and inner ear disorders. The Company was founded in 2003 and is headquartered in Hamilton, Bermuda with its main operations in Basel, Switzerland. The shares of Altamira Therapeutics Ltd. trade on the NASDAQ Capital Market under the symbol “CYTO.”

Latest Events

Altamira Therapeutics Issues Spring 2022 Shareholder Letter

View PDF

Altamira Therapeutics Sets Full Year 2021 Earnings Call
Tuesday, April 12, 2022, 8:00 a.m. ET
Toll-free Replay: 877-481-4010
International Replay: 919-882-2331
Replay Access Code: 45151

Stock Quote


Recent Press Releases

Investor Contact

Primary IR Contacts
E-Mail: or
U.S Tel: 800-460-0183